Global Vaccines For Children (VFC) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
Page: 114
Published Date: 20 Jan 2024
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
According to our (Global Info Research) latest study, the global Vaccines For Children (VFC) market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Vaccines For Children (VFC) industry chain, the market status of Government Institution (Recombinant Vaccines, Viral Vaccines), Private Sector (Recombinant Vaccines, Viral Vaccines), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Vaccines For Children (VFC).
Regionally, the report analyzes the Vaccines For Children (VFC) markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Vaccines For Children (VFC) market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Vaccines For Children (VFC) market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Vaccines For Children (VFC) industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Doses), revenue generated, and market share of different by Type (e.g., Recombinant Vaccines, Viral Vaccines).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Vaccines For Children (VFC) market.
Regional Analysis: The report involves examining the Vaccines For Children (VFC) market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Vaccines For Children (VFC) market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Vaccines For Children (VFC):
Company Analysis: Report covers individual Vaccines For Children (VFC) manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Vaccines For Children (VFC) This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Government Institution, Private Sector).
Technology Analysis: Report covers specific technologies relevant to Vaccines For Children (VFC). It assesses the current state, advancements, and potential future developments in Vaccines For Children (VFC) areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Vaccines For Children (VFC) market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Vaccines For Children (VFC) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Recombinant Vaccines
Viral Vaccines
Polysaccharide Vaccines
Others
Market segment by Application
Government Institution
Private Sector
Other
Major players covered
GSK
Sanofi
Merck
Pfizer
Jintan
CSL
MedImmune LLC
J&J(Crucell)
China National Biotec
Tiantan
Hualan
Kangtai
Hissen
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Vaccines For Children (VFC) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Vaccines For Children (VFC), with price, sales, revenue and global market share of Vaccines For Children (VFC) from 2019 to 2024.
Chapter 3, the Vaccines For Children (VFC) competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Vaccines For Children (VFC) breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Vaccines For Children (VFC) market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Vaccines For Children (VFC).
Chapter 14 and 15, to describe Vaccines For Children (VFC) sales channel, distributors, customers, research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Vaccines For Children (VFC)
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Vaccines For Children (VFC) Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Recombinant Vaccines
1.3.3 Viral Vaccines
1.3.4 Polysaccharide Vaccines
1.3.5 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Vaccines For Children (VFC) Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Government Institution
1.4.3 Private Sector
1.4.4 Other
1.5 Global Vaccines For Children (VFC) Market Size & Forecast
1.5.1 Global Vaccines For Children (VFC) Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Vaccines For Children (VFC) Sales Quantity (2019-2030)
1.5.3 Global Vaccines For Children (VFC) Average Price (2019-2030)
2.1 GSK
2.1.1 GSK Details
2.1.2 GSK Major Business
2.1.3 GSK Vaccines For Children (VFC) Product and Services
2.1.4 GSK Vaccines For Children (VFC) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 GSK Recent Developments/Updates
2.2 Sanofi
2.2.1 Sanofi Details
2.2.2 Sanofi Major Business
2.2.3 Sanofi Vaccines For Children (VFC) Product and Services
2.2.4 Sanofi Vaccines For Children (VFC) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Sanofi Recent Developments/Updates
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business
2.3.3 Merck Vaccines For Children (VFC) Product and Services
2.3.4 Merck Vaccines For Children (VFC) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Merck Recent Developments/Updates
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer Vaccines For Children (VFC) Product and Services
2.4.4 Pfizer Vaccines For Children (VFC) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Pfizer Recent Developments/Updates
2.5 Jintan
2.5.1 Jintan Details
2.5.2 Jintan Major Business
2.5.3 Jintan Vaccines For Children (VFC) Product and Services
2.5.4 Jintan Vaccines For Children (VFC) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Jintan Recent Developments/Updates
2.6 CSL
2.6.1 CSL Details
2.6.2 CSL Major Business
2.6.3 CSL Vaccines For Children (VFC) Product and Services
2.6.4 CSL Vaccines For Children (VFC) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 CSL Recent Developments/Updates
2.7 MedImmune LLC
2.7.1 MedImmune LLC Details
2.7.2 MedImmune LLC Major Business
2.7.3 MedImmune LLC Vaccines For Children (VFC) Product and Services
2.7.4 MedImmune LLC Vaccines For Children (VFC) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 MedImmune LLC Recent Developments/Updates
2.8 J&J(Crucell)
2.8.1 J&J(Crucell) Details
2.8.2 J&J(Crucell) Major Business
2.8.3 J&J(Crucell) Vaccines For Children (VFC) Product and Services
2.8.4 J&J(Crucell) Vaccines For Children (VFC) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 J&J(Crucell) Recent Developments/Updates
2.9 China National Biotec
2.9.1 China National Biotec Details
2.9.2 China National Biotec Major Business
2.9.3 China National Biotec Vaccines For Children (VFC) Product and Services
2.9.4 China National Biotec Vaccines For Children (VFC) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 China National Biotec Recent Developments/Updates
2.10 Tiantan
2.10.1 Tiantan Details
2.10.2 Tiantan Major Business
2.10.3 Tiantan Vaccines For Children (VFC) Product and Services
2.10.4 Tiantan Vaccines For Children (VFC) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Tiantan Recent Developments/Updates
2.11 Hualan
2.11.1 Hualan Details
2.11.2 Hualan Major Business
2.11.3 Hualan Vaccines For Children (VFC) Product and Services
2.11.4 Hualan Vaccines For Children (VFC) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Hualan Recent Developments/Updates
2.12 Kangtai
2.12.1 Kangtai Details
2.12.2 Kangtai Major Business
2.12.3 Kangtai Vaccines For Children (VFC) Product and Services
2.12.4 Kangtai Vaccines For Children (VFC) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Kangtai Recent Developments/Updates
2.13 Hissen
2.13.1 Hissen Details
2.13.2 Hissen Major Business
2.13.3 Hissen Vaccines For Children (VFC) Product and Services
2.13.4 Hissen Vaccines For Children (VFC) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Hissen Recent Developments/Updates
3.1 Global Vaccines For Children (VFC) Sales Quantity by Manufacturer (2019-2024)
3.2 Global Vaccines For Children (VFC) Revenue by Manufacturer (2019-2024)
3.3 Global Vaccines For Children (VFC) Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Vaccines For Children (VFC) by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Vaccines For Children (VFC) Manufacturer Market Share in 2023
3.4.2 Top 6 Vaccines For Children (VFC) Manufacturer Market Share in 2023
3.5 Vaccines For Children (VFC) Market: Overall Company Footprint Analysis
3.5.1 Vaccines For Children (VFC) Market: Region Footprint
3.5.2 Vaccines For Children (VFC) Market: Company Product Type Footprint
3.5.3 Vaccines For Children (VFC) Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global Vaccines For Children (VFC) Market Size by Region
4.1.1 Global Vaccines For Children (VFC) Sales Quantity by Region (2019-2030)
4.1.2 Global Vaccines For Children (VFC) Consumption Value by Region (2019-2030)
4.1.3 Global Vaccines For Children (VFC) Average Price by Region (2019-2030)
4.2 North America Vaccines For Children (VFC) Consumption Value (2019-2030)
4.3 Europe Vaccines For Children (VFC) Consumption Value (2019-2030)
4.4 Asia-Pacific Vaccines For Children (VFC) Consumption Value (2019-2030)
4.5 South America Vaccines For Children (VFC) Consumption Value (2019-2030)
4.6 Middle East and Africa Vaccines For Children (VFC) Consumption Value (2019-2030)
5.1 Global Vaccines For Children (VFC) Sales Quantity by Type (2019-2030)
5.2 Global Vaccines For Children (VFC) Consumption Value by Type (2019-2030)
5.3 Global Vaccines For Children (VFC) Average Price by Type (2019-2030)
6.1 Global Vaccines For Children (VFC) Sales Quantity by Application (2019-2030)
6.2 Global Vaccines For Children (VFC) Consumption Value by Application (2019-2030)
6.3 Global Vaccines For Children (VFC) Average Price by Application (2019-2030)
7.1 North America Vaccines For Children (VFC) Sales Quantity by Type (2019-2030)
7.2 North America Vaccines For Children (VFC) Sales Quantity by Application (2019-2030)
7.3 North America Vaccines For Children (VFC) Market Size by Country
7.3.1 North America Vaccines For Children (VFC) Sales Quantity by Country (2019-2030)
7.3.2 North America Vaccines For Children (VFC) Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8.1 Europe Vaccines For Children (VFC) Sales Quantity by Type (2019-2030)
8.2 Europe Vaccines For Children (VFC) Sales Quantity by Application (2019-2030)
8.3 Europe Vaccines For Children (VFC) Market Size by Country
8.3.1 Europe Vaccines For Children (VFC) Sales Quantity by Country (2019-2030)
8.3.2 Europe Vaccines For Children (VFC) Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9.1 Asia-Pacific Vaccines For Children (VFC) Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Vaccines For Children (VFC) Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Vaccines For Children (VFC) Market Size by Region
9.3.1 Asia-Pacific Vaccines For Children (VFC) Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Vaccines For Children (VFC) Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10.1 South America Vaccines For Children (VFC) Sales Quantity by Type (2019-2030)
10.2 South America Vaccines For Children (VFC) Sales Quantity by Application (2019-2030)
10.3 South America Vaccines For Children (VFC) Market Size by Country
10.3.1 South America Vaccines For Children (VFC) Sales Quantity by Country (2019-2030)
10.3.2 South America Vaccines For Children (VFC) Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11.1 Middle East & Africa Vaccines For Children (VFC) Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Vaccines For Children (VFC) Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Vaccines For Children (VFC) Market Size by Country
11.3.1 Middle East & Africa Vaccines For Children (VFC) Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Vaccines For Children (VFC) Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12.1 Vaccines For Children (VFC) Market Drivers
12.2 Vaccines For Children (VFC) Market Restraints
12.3 Vaccines For Children (VFC) Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13.1 Raw Material of Vaccines For Children (VFC) and Key Manufacturers
13.2 Manufacturing Costs Percentage of Vaccines For Children (VFC)
13.3 Vaccines For Children (VFC) Production Process
13.4 Vaccines For Children (VFC) Industrial Chain
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Vaccines For Children (VFC) Typical Distributors
14.3 Vaccines For Children (VFC) Typical Customers
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Vaccines For Children (VFC) Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Vaccines For Children (VFC) Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. GSK Basic Information, Manufacturing Base and Competitors
Table 4. GSK Major Business
Table 5. GSK Vaccines For Children (VFC) Product and Services
Table 6. GSK Vaccines For Children (VFC) Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. GSK Recent Developments/Updates
Table 8. Sanofi Basic Information, Manufacturing Base and Competitors
Table 9. Sanofi Major Business
Table 10. Sanofi Vaccines For Children (VFC) Product and Services
Table 11. Sanofi Vaccines For Children (VFC) Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Sanofi Recent Developments/Updates
Table 13. Merck Basic Information, Manufacturing Base and Competitors
Table 14. Merck Major Business
Table 15. Merck Vaccines For Children (VFC) Product and Services
Table 16. Merck Vaccines For Children (VFC) Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Merck Recent Developments/Updates
Table 18. Pfizer Basic Information, Manufacturing Base and Competitors
Table 19. Pfizer Major Business
Table 20. Pfizer Vaccines For Children (VFC) Product and Services
Table 21. Pfizer Vaccines For Children (VFC) Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Pfizer Recent Developments/Updates
Table 23. Jintan Basic Information, Manufacturing Base and Competitors
Table 24. Jintan Major Business
Table 25. Jintan Vaccines For Children (VFC) Product and Services
Table 26. Jintan Vaccines For Children (VFC) Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Jintan Recent Developments/Updates
Table 28. CSL Basic Information, Manufacturing Base and Competitors
Table 29. CSL Major Business
Table 30. CSL Vaccines For Children (VFC) Product and Services
Table 31. CSL Vaccines For Children (VFC) Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. CSL Recent Developments/Updates
Table 33. MedImmune LLC Basic Information, Manufacturing Base and Competitors
Table 34. MedImmune LLC Major Business
Table 35. MedImmune LLC Vaccines For Children (VFC) Product and Services
Table 36. MedImmune LLC Vaccines For Children (VFC) Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. MedImmune LLC Recent Developments/Updates
Table 38. J&J(Crucell) Basic Information, Manufacturing Base and Competitors
Table 39. J&J(Crucell) Major Business
Table 40. J&J(Crucell) Vaccines For Children (VFC) Product and Services
Table 41. J&J(Crucell) Vaccines For Children (VFC) Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. J&J(Crucell) Recent Developments/Updates
Table 43. China National Biotec Basic Information, Manufacturing Base and Competitors
Table 44. China National Biotec Major Business
Table 45. China National Biotec Vaccines For Children (VFC) Product and Services
Table 46. China National Biotec Vaccines For Children (VFC) Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. China National Biotec Recent Developments/Updates
Table 48. Tiantan Basic Information, Manufacturing Base and Competitors
Table 49. Tiantan Major Business
Table 50. Tiantan Vaccines For Children (VFC) Product and Services
Table 51. Tiantan Vaccines For Children (VFC) Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Tiantan Recent Developments/Updates
Table 53. Hualan Basic Information, Manufacturing Base and Competitors
Table 54. Hualan Major Business
Table 55. Hualan Vaccines For Children (VFC) Product and Services
Table 56. Hualan Vaccines For Children (VFC) Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. Hualan Recent Developments/Updates
Table 58. Kangtai Basic Information, Manufacturing Base and Competitors
Table 59. Kangtai Major Business
Table 60. Kangtai Vaccines For Children (VFC) Product and Services
Table 61. Kangtai Vaccines For Children (VFC) Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 62. Kangtai Recent Developments/Updates
Table 63. Hissen Basic Information, Manufacturing Base and Competitors
Table 64. Hissen Major Business
Table 65. Hissen Vaccines For Children (VFC) Product and Services
Table 66. Hissen Vaccines For Children (VFC) Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 67. Hissen Recent Developments/Updates
Table 68. Global Vaccines For Children (VFC) Sales Quantity by Manufacturer (2019-2024) & (K Doses)
Table 69. Global Vaccines For Children (VFC) Revenue by Manufacturer (2019-2024) & (USD Million)
Table 70. Global Vaccines For Children (VFC) Average Price by Manufacturer (2019-2024) & (US$/Dose)
Table 71. Market Position of Manufacturers in Vaccines For Children (VFC), (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 72. Head Office and Vaccines For Children (VFC) Production Site of Key Manufacturer
Table 73. Vaccines For Children (VFC) Market: Company Product Type Footprint
Table 74. Vaccines For Children (VFC) Market: Company Product Application Footprint
Table 75. Vaccines For Children (VFC) New Market Entrants and Barriers to Market Entry
Table 76. Vaccines For Children (VFC) Mergers, Acquisition, Agreements, and Collaborations
Table 77. Global Vaccines For Children (VFC) Sales Quantity by Region (2019-2024) & (K Doses)
Table 78. Global Vaccines For Children (VFC) Sales Quantity by Region (2025-2030) & (K Doses)
Table 79. Global Vaccines For Children (VFC) Consumption Value by Region (2019-2024) & (USD Million)
Table 80. Global Vaccines For Children (VFC) Consumption Value by Region (2025-2030) & (USD Million)
Table 81. Global Vaccines For Children (VFC) Average Price by Region (2019-2024) & (US$/Dose)
Table 82. Global Vaccines For Children (VFC) Average Price by Region (2025-2030) & (US$/Dose)
Table 83. Global Vaccines For Children (VFC) Sales Quantity by Type (2019-2024) & (K Doses)
Table 84. Global Vaccines For Children (VFC) Sales Quantity by Type (2025-2030) & (K Doses)
Table 85. Global Vaccines For Children (VFC) Consumption Value by Type (2019-2024) & (USD Million)
Table 86. Global Vaccines For Children (VFC) Consumption Value by Type (2025-2030) & (USD Million)
Table 87. Global Vaccines For Children (VFC) Average Price by Type (2019-2024) & (US$/Dose)
Table 88. Global Vaccines For Children (VFC) Average Price by Type (2025-2030) & (US$/Dose)
Table 89. Global Vaccines For Children (VFC) Sales Quantity by Application (2019-2024) & (K Doses)
Table 90. Global Vaccines For Children (VFC) Sales Quantity by Application (2025-2030) & (K Doses)
Table 91. Global Vaccines For Children (VFC) Consumption Value by Application (2019-2024) & (USD Million)
Table 92. Global Vaccines For Children (VFC) Consumption Value by Application (2025-2030) & (USD Million)
Table 93. Global Vaccines For Children (VFC) Average Price by Application (2019-2024) & (US$/Dose)
Table 94. Global Vaccines For Children (VFC) Average Price by Application (2025-2030) & (US$/Dose)
Table 95. North America Vaccines For Children (VFC) Sales Quantity by Type (2019-2024) & (K Doses)
Table 96. North America Vaccines For Children (VFC) Sales Quantity by Type (2025-2030) & (K Doses)
Table 97. North America Vaccines For Children (VFC) Sales Quantity by Application (2019-2024) & (K Doses)
Table 98. North America Vaccines For Children (VFC) Sales Quantity by Application (2025-2030) & (K Doses)
Table 99. North America Vaccines For Children (VFC) Sales Quantity by Country (2019-2024) & (K Doses)
Table 100. North America Vaccines For Children (VFC) Sales Quantity by Country (2025-2030) & (K Doses)
Table 101. North America Vaccines For Children (VFC) Consumption Value by Country (2019-2024) & (USD Million)
Table 102. North America Vaccines For Children (VFC) Consumption Value by Country (2025-2030) & (USD Million)
Table 103. Europe Vaccines For Children (VFC) Sales Quantity by Type (2019-2024) & (K Doses)
Table 104. Europe Vaccines For Children (VFC) Sales Quantity by Type (2025-2030) & (K Doses)
Table 105. Europe Vaccines For Children (VFC) Sales Quantity by Application (2019-2024) & (K Doses)
Table 106. Europe Vaccines For Children (VFC) Sales Quantity by Application (2025-2030) & (K Doses)
Table 107. Europe Vaccines For Children (VFC) Sales Quantity by Country (2019-2024) & (K Doses)
Table 108. Europe Vaccines For Children (VFC) Sales Quantity by Country (2025-2030) & (K Doses)
Table 109. Europe Vaccines For Children (VFC) Consumption Value by Country (2019-2024) & (USD Million)
Table 110. Europe Vaccines For Children (VFC) Consumption Value by Country (2025-2030) & (USD Million)
Table 111. Asia-Pacific Vaccines For Children (VFC) Sales Quantity by Type (2019-2024) & (K Doses)
Table 112. Asia-Pacific Vaccines For Children (VFC) Sales Quantity by Type (2025-2030) & (K Doses)
Table 113. Asia-Pacific Vaccines For Children (VFC) Sales Quantity by Application (2019-2024) & (K Doses)
Table 114. Asia-Pacific Vaccines For Children (VFC) Sales Quantity by Application (2025-2030) & (K Doses)
Table 115. Asia-Pacific Vaccines For Children (VFC) Sales Quantity by Region (2019-2024) & (K Doses)
Table 116. Asia-Pacific Vaccines For Children (VFC) Sales Quantity by Region (2025-2030) & (K Doses)
Table 117. Asia-Pacific Vaccines For Children (VFC) Consumption Value by Region (2019-2024) & (USD Million)
Table 118. Asia-Pacific Vaccines For Children (VFC) Consumption Value by Region (2025-2030) & (USD Million)
Table 119. South America Vaccines For Children (VFC) Sales Quantity by Type (2019-2024) & (K Doses)
Table 120. South America Vaccines For Children (VFC) Sales Quantity by Type (2025-2030) & (K Doses)
Table 121. South America Vaccines For Children (VFC) Sales Quantity by Application (2019-2024) & (K Doses)
Table 122. South America Vaccines For Children (VFC) Sales Quantity by Application (2025-2030) & (K Doses)
Table 123. South America Vaccines For Children (VFC) Sales Quantity by Country (2019-2024) & (K Doses)
Table 124. South America Vaccines For Children (VFC) Sales Quantity by Country (2025-2030) & (K Doses)
Table 125. South America Vaccines For Children (VFC) Consumption Value by Country (2019-2024) & (USD Million)
Table 126. South America Vaccines For Children (VFC) Consumption Value by Country (2025-2030) & (USD Million)
Table 127. Middle East & Africa Vaccines For Children (VFC) Sales Quantity by Type (2019-2024) & (K Doses)
Table 128. Middle East & Africa Vaccines For Children (VFC) Sales Quantity by Type (2025-2030) & (K Doses)
Table 129. Middle East & Africa Vaccines For Children (VFC) Sales Quantity by Application (2019-2024) & (K Doses)
Table 130. Middle East & Africa Vaccines For Children (VFC) Sales Quantity by Application (2025-2030) & (K Doses)
Table 131. Middle East & Africa Vaccines For Children (VFC) Sales Quantity by Region (2019-2024) & (K Doses)
Table 132. Middle East & Africa Vaccines For Children (VFC) Sales Quantity by Region (2025-2030) & (K Doses)
Table 133. Middle East & Africa Vaccines For Children (VFC) Consumption Value by Region (2019-2024) & (USD Million)
Table 134. Middle East & Africa Vaccines For Children (VFC) Consumption Value by Region (2025-2030) & (USD Million)
Table 135. Vaccines For Children (VFC) Raw Material
Table 136. Key Manufacturers of Vaccines For Children (VFC) Raw Materials
Table 137. Vaccines For Children (VFC) Typical Distributors
Table 138. Vaccines For Children (VFC) Typical Customers
List of Figures
Figure 1. Vaccines For Children (VFC) Picture
Figure 2. Global Vaccines For Children (VFC) Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Vaccines For Children (VFC) Consumption Value Market Share by Type in 2023
Figure 4. Recombinant Vaccines Examples
Figure 5. Viral Vaccines Examples
Figure 6. Polysaccharide Vaccines Examples
Figure 7. Others Examples
Figure 8. Global Vaccines For Children (VFC) Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 9. Global Vaccines For Children (VFC) Consumption Value Market Share by Application in 2023
Figure 10. Government Institution Examples
Figure 11. Private Sector Examples
Figure 12. Other Examples
Figure 13. Global Vaccines For Children (VFC) Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 14. Global Vaccines For Children (VFC) Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 15. Global Vaccines For Children (VFC) Sales Quantity (2019-2030) & (K Doses)
Figure 16. Global Vaccines For Children (VFC) Average Price (2019-2030) & (US$/Dose)
Figure 17. Global Vaccines For Children (VFC) Sales Quantity Market Share by Manufacturer in 2023
Figure 18. Global Vaccines For Children (VFC) Consumption Value Market Share by Manufacturer in 2023
Figure 19. Producer Shipments of Vaccines For Children (VFC) by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 20. Top 3 Vaccines For Children (VFC) Manufacturer (Consumption Value) Market Share in 2023
Figure 21. Top 6 Vaccines For Children (VFC) Manufacturer (Consumption Value) Market Share in 2023
Figure 22. Global Vaccines For Children (VFC) Sales Quantity Market Share by Region (2019-2030)
Figure 23. Global Vaccines For Children (VFC) Consumption Value Market Share by Region (2019-2030)
Figure 24. North America Vaccines For Children (VFC) Consumption Value (2019-2030) & (USD Million)
Figure 25. Europe Vaccines For Children (VFC) Consumption Value (2019-2030) & (USD Million)
Figure 26. Asia-Pacific Vaccines For Children (VFC) Consumption Value (2019-2030) & (USD Million)
Figure 27. South America Vaccines For Children (VFC) Consumption Value (2019-2030) & (USD Million)
Figure 28. Middle East & Africa Vaccines For Children (VFC) Consumption Value (2019-2030) & (USD Million)
Figure 29. Global Vaccines For Children (VFC) Sales Quantity Market Share by Type (2019-2030)
Figure 30. Global Vaccines For Children (VFC) Consumption Value Market Share by Type (2019-2030)
Figure 31. Global Vaccines For Children (VFC) Average Price by Type (2019-2030) & (US$/Dose)
Figure 32. Global Vaccines For Children (VFC) Sales Quantity Market Share by Application (2019-2030)
Figure 33. Global Vaccines For Children (VFC) Consumption Value Market Share by Application (2019-2030)
Figure 34. Global Vaccines For Children (VFC) Average Price by Application (2019-2030) & (US$/Dose)
Figure 35. North America Vaccines For Children (VFC) Sales Quantity Market Share by Type (2019-2030)
Figure 36. North America Vaccines For Children (VFC) Sales Quantity Market Share by Application (2019-2030)
Figure 37. North America Vaccines For Children (VFC) Sales Quantity Market Share by Country (2019-2030)
Figure 38. North America Vaccines For Children (VFC) Consumption Value Market Share by Country (2019-2030)
Figure 39. United States Vaccines For Children (VFC) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Canada Vaccines For Children (VFC) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Mexico Vaccines For Children (VFC) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 42. Europe Vaccines For Children (VFC) Sales Quantity Market Share by Type (2019-2030)
Figure 43. Europe Vaccines For Children (VFC) Sales Quantity Market Share by Application (2019-2030)
Figure 44. Europe Vaccines For Children (VFC) Sales Quantity Market Share by Country (2019-2030)
Figure 45. Europe Vaccines For Children (VFC) Consumption Value Market Share by Country (2019-2030)
Figure 46. Germany Vaccines For Children (VFC) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. France Vaccines For Children (VFC) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. United Kingdom Vaccines For Children (VFC) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Russia Vaccines For Children (VFC) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Italy Vaccines For Children (VFC) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. Asia-Pacific Vaccines For Children (VFC) Sales Quantity Market Share by Type (2019-2030)
Figure 52. Asia-Pacific Vaccines For Children (VFC) Sales Quantity Market Share by Application (2019-2030)
Figure 53. Asia-Pacific Vaccines For Children (VFC) Sales Quantity Market Share by Region (2019-2030)
Figure 54. Asia-Pacific Vaccines For Children (VFC) Consumption Value Market Share by Region (2019-2030)
Figure 55. China Vaccines For Children (VFC) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Japan Vaccines For Children (VFC) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Korea Vaccines For Children (VFC) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. India Vaccines For Children (VFC) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Southeast Asia Vaccines For Children (VFC) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. Australia Vaccines For Children (VFC) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. South America Vaccines For Children (VFC) Sales Quantity Market Share by Type (2019-2030)
Figure 62. South America Vaccines For Children (VFC) Sales Quantity Market Share by Application (2019-2030)
Figure 63. South America Vaccines For Children (VFC) Sales Quantity Market Share by Country (2019-2030)
Figure 64. South America Vaccines For Children (VFC) Consumption Value Market Share by Country (2019-2030)
Figure 65. Brazil Vaccines For Children (VFC) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 66. Argentina Vaccines For Children (VFC) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 67. Middle East & Africa Vaccines For Children (VFC) Sales Quantity Market Share by Type (2019-2030)
Figure 68. Middle East & Africa Vaccines For Children (VFC) Sales Quantity Market Share by Application (2019-2030)
Figure 69. Middle East & Africa Vaccines For Children (VFC) Sales Quantity Market Share by Region (2019-2030)
Figure 70. Middle East & Africa Vaccines For Children (VFC) Consumption Value Market Share by Region (2019-2030)
Figure 71. Turkey Vaccines For Children (VFC) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Egypt Vaccines For Children (VFC) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. Saudi Arabia Vaccines For Children (VFC) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. South Africa Vaccines For Children (VFC) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 75. Vaccines For Children (VFC) Market Drivers
Figure 76. Vaccines For Children (VFC) Market Restraints
Figure 77. Vaccines For Children (VFC) Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of Vaccines For Children (VFC) in 2023
Figure 80. Manufacturing Process Analysis of Vaccines For Children (VFC)
Figure 81. Vaccines For Children (VFC) Industrial Chain
Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
GSK Sanofi Merck Pfizer Jintan CSL MedImmune LLC J&J(Crucell) China National Biotec Tiantan Hualan Kangtai Hissen
Related Reports
07 Jan 2023
Pharma & Healthcare
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
